Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications
Aino Soro‐Paavonen(Helsinki University Hospital), Per‐Henrik Groop(University of Helsinki), Milla Rosengård‐Bärlund, Carol Forsblom(University of Helsinki), Merlin C. Thomas(Monash University), Daniel Gordin(Helsinki University Hospital), Niina Sandholm(University of Helsinki), Lena M. Thorn(University of Helsinki), Johan Wadén(Helsinki University Hospital)
Cited by 215
Related Papers
Diabetic kidney disease
|Nature Reviews Disease Primers|2015|1.2k
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428